The France Therapeutic Hypothermia Systems Market was valued at $11 Million in 2023 and projected to reach to $14.6 Million by 2028, representing a compound annual growth rate of 5.8%. France's therapeutic hypothermia systems market is positioned for steady growth through 2028, supported by the country's commitment to advanced healthcare technologies and evidence-based clinical practices.
| Market Size in | USD 26.32 MN |
| Market Forecast in | |
| CAGR | |
| Forecast Period | |
| Units Considered | Value (USD MN) |
France's therapeutic hypothermia systems market reached $11.0 million in 2023, with projections to expand to $14.6 million by 2028, demonstrating consistent growth in temperature management technology adoption.
The French market is experiencing a 5.8% CAGR, slightly below the global average of 6.3%, reflecting steady but measured expansion driven by healthcare modernization and clinical protocol adoption.
France's robust healthcare system and advanced medical facilities provide a strong foundation for therapeutic hypothermia system deployment, particularly in cardiac care and neurological recovery applications.
Increasing recognition of therapeutic hypothermia benefits in post-cardiac arrest care and stroke management is accelerating adoption among French hospitals and specialized medical centers.
| Report Metric | Details |
|---|---|
| Base Year | 2023 |
| Fastest Growing Segment | CARDIOLOGY (Application) |
| Forecast Period | 2023-2028 |
| Growth Rate | CAGR of 6.3% from 2023 to 2028 |
| Largest Segment | COOLING DEVICES (Product) |
| Market Size Base Year (Billions) | ~USD 0.29 (2023) |
| Revenue Forecast (Billions) | ~USD 0.4 (2028) |
| Segments Covered | Product, Application, Volume |
3 segment dimensions are covered across the global market.
| Segment | 2021 | 2022 | 2023 | 2024 | 2025 | 2026 | 2027 | 2028 | CAGR (%) |
|---|---|---|---|---|---|---|---|---|---|
| CARDIOLOGY | 7.1 | 7.5 | 7.9 | 8.4 | 8.8 | 9.3 | 9.9 | 10.5 | 5.9 |
| NEONATAL CARE | 1.2 | 1.3 | 1.4 | 1.4 | 1.5 | 1.6 | 1.6 | 1.7 | 4 |
| NEUROLOGY | 8 | 8.5 | 8.9 | 9.4 | 9.9 | 10.5 | 11.1 | 11.8 | 5.8 |
| OTHER APPLICATIONS | 0.9 | 1 | 1 | 1 | 1.1 | 1.1 | 1.2 | 1.2 | 3.7 |
| TOTAL | 17.2 | 18.3 | 19.2 | 20.2 | 21.3 | 22.5 | 23.8 | 25.2 | 5.6 |
France's therapeutic hypothermia systems market was valued at $11.0 million in 2023 and is expected to grow to $14.6 million by 2028.
France's therapeutic hypothermia systems market is projected to grow at a compound annual growth rate (CAGR) of 5.8% from 2023 to 2028.
In France, primary applications include post-cardiac arrest care, neurological protection following stroke, and traumatic brain injury management in critical care settings.
France's established reimbursement pathways, regulatory frameworks, and integration into standard post-resuscitation protocols facilitate widespread adoption of therapeutic hypothermia systems across hospitals.
France's aging population and rising prevalence of cardiac events are key demographic drivers supporting increased demand for therapeutic hypothermia systems through 2028.
The objective of the study is to analyze the key market dynamics, such as drivers, opportunities, challenges, restraints, and key player strategies. To track company developments such as acquisitions, product launches, expansions, collaborations, agreements, and partnerships of the leading players, the competitive landscape of the therapeutic hypothermia systems market to analyze market players on various parameters within the broad categories of business and product strategy. Top-down and bottom-up approaches were used to estimate the market size. To estimate the market size of segments and subsegments, the market breakdown and data triangulation were used.
The four steps involved in estimating the market size are
The secondary research data collection process involves the usage of secondary sources, directories, databases (such as Bloomberg Businessweek, Factiva, and D&B), annual reports, investor presentations, and SEC filings of companies. Secondary research was used to identify and collect information useful for the extensive, technical, market-oriented, and commercial study of the market. A database of the key industry leaders was also prepared using secondary research.
The primary research data was conducted after acquiring knowledge about the market scenario through secondary research. A significant number of primary interviews were conducted with stakeholders from both the demand side (such as pharmaceutical & biotechnology industries, food & nutraceutical industries, and research laboratories) and supply side (such as included various industry experts, such as Directors, Chief X Officers (CXOs), Vice Presidents (VPs) from business development, marketing, and product development teams, product manufacturers, wholesalers, channel partners, and distributors) across major countries of North America, Europe, Asia Pacific, the Middle East & Africa, and Latin America. Approximately 40% of the primary interviews were conducted with stakeholders from the demand side, while those from the supply side accounted for the remaining 60%. Primary data for this report was collected through questionnaires, emails, and telephonic interviews.
A breakdown of the primary respondents is provided below:

Note 1: *Others include sales managers, marketing managers, and product managers.
Note 2: Tiers are defined based on a company’s total revenue as of 2022: Tier 1=> USD 1 billion, Tier 2 = USD 500 million to USD 1 billion, and Tier 3=< USD 500 million.
To know about the assumptions considered for the study, download the pdf brochure
All major product manufacturers offering various therapeutic hypothermia systems were identified at the global/regional level. Revenue mapping was done for the major players and was extrapolated to arrive at the global market value of each type of segment. The market value therapeutic hypothermia systems market was also split into various segments and subsegments at the region and country level based on:

To know about the assumptions considered for the study, Request for Free Sample Report

After arriving at the overall market size—using the market size estimation processes—the market was split into several segments and subsegments. To complete the overall market engineering process and arrive at the exact statistics of each market segment and subsegment, data triangulation and market breakdown procedures were employed, wherever applicable. The data was triangulated by studying various factors and trends from both the demand and supply sides in the Therapeutic hypothermia systems industry.
Therapeutic hypothermia, also known as targeted temperature management or induced hypothermia, is a medical treatment that involves lowering a patient’s body temperature for a specific period to provide therapeutic benefits. This intervention is often employed in certain medical conditions to reduce the risk of injury to tissues, particularly the brain, and improve overall outcomes. The primary goal of therapeutic hypothermia is to protect the body’s organs, especially the brain, from damage following events such as cardiac arrest, traumatic brain injury, stroke, or neonatal hypoxic-ischemic encephalopathy (a type of brain injury that occurs when there is a lack of oxygen and blood flow to the brain in newborns).
MarketsandMarkets offers the following customizations for this market report:
Full forecast, segment splits, and company analysis for all Therapeutic Hypothermia Systems Market.
Customize this report to your needs
Get 10% FREE Customization
Customize This Report